Literature DB >> 16506946

Transactivating transcriptional activator-mediated drug delivery.

Bhawna Gupta1, Vladimir P Torchilin.   

Abstract

Cell-penetrating peptides (CPPs) are peptide vectors that can traverse through the plasma membrane barrier without breaching the integrity of the cell, and deliver various cargoes inside cell. The range of cargoes that can be delivered intracellularly by CPPs encompasses a broad variety of hydrophilic molecules, such as peptides, proteins, antibodies, imaging agents, DNA and even nanosized entities, including polymer-based systems, solid nanoparticles and liposomes. Multiple studies have focused on CPPs such as transactivating transcriptional activator peptide (TATp), penetratin, VP22, transportan and synthetic oligoarginines because of their high inherent potential as intracellular delivery vectors. However, the TATp remains the most popular CPP used for a variety of purposes. This review article attempts to bring together the available data on TAT-mediated intracellular uptake of a broad range of molecules and nanoparticles. It also considers potential practical applications of this approach.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16506946     DOI: 10.1517/17425247.3.2.177

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  13 in total

1.  Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.

Authors:  Ondrej Stanek; Irena Linhartova; Laleh Majlessi; Claude Leclerc; Peter Sebo
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

2.  Successful TAT-mediated enzyme replacement therapy in a mouse model of mitochondrial E3 deficiency.

Authors:  Matan Rapoport; Lina Salman; Ofra Sabag; Mulchand S Patel; Haya Lorberboum-Galski
Journal:  J Mol Med (Berl)       Date:  2010-11-16       Impact factor: 4.599

Review 3.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

Review 4.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

Review 5.  Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor.

Authors:  Yinghuan Li; Jie Wang; M Guillaume Wientjes; Jessie L-S Au
Journal:  Adv Drug Deliv Rev       Date:  2011-05-03       Impact factor: 15.470

6.  Tat-Mediated Peptide Intervention in Analgesia and Anesthesia.

Authors:  Feng Tao; Roger A Johns
Journal:  Drug Dev Res       Date:  2010-04-01       Impact factor: 4.360

7.  Neuroprotective effect of TAT PTD-Ngb fusion protein on primary cortical neurons against hypoxia-induced apoptosis.

Authors:  Guoyu Zhou; Peiyan Shan; Xueqiang Hu; Xueping Zheng; Shengnian Zhou
Journal:  Neurol Sci       Date:  2013-03-02       Impact factor: 3.307

8.  "Soft" calcium crosslinks enable highly efficient gene transfection using TAT peptide.

Authors:  Abdulgader Baoum; Sheng-Xue Xie; Amir Fakhari; Cory Berkland
Journal:  Pharm Res       Date:  2009-09-30       Impact factor: 4.200

9.  Protein transduction domain can enhance the humoral immunity and cross-protection of HPV16L2 peptide vaccines.

Authors:  Lili Li; Yantao Guo; Zelin Li; Yubai Zhou; Y I Zeng
Journal:  Biomed Rep       Date:  2016-04-07

10.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.